tirzepatide for anxiety and depression Does Help with or Make It Worse? GLP-1s linked to lower rates

The pharmaceutical companies adoption of a financialized business model prioritizes profits and shareholder returns through an aggressive strategy for securing additional patents for minor changes to extend their drugs market exclusivity well beyond the expiration of its original patents, according to a report released Thursday by the Initiative for Medicines, Access and Knowledge on the heavy price of those glucagon-like

GLP-1 analogues did not increase the risk for pancreatic cancer when compared to the control OR 1.06

Some individuals may also experience changes in blood sugar levels

Summary: GLP-1 receptor agonists are not licensed for anxiety treatment and lack established evidence for direct anxiolytic effects, though some patients may experience secondary psychological improvements through metabolic health gains

Chauhan A, Chauhan V, Brown WT, Cohen I